Bullfrog AI appoints GSK veteran Dr. John Baldoni to Scientific Advisory Board

BullFrog AI Holdings, Inc.

Dr. Baldoni brings 40+ years of pharma experience, including 29 years at GSK as SVP of Platform and Technology Sciences.
He contributed to scores of commercial products and co-founded the ATOM consortium for AI-driven drug development.
CEO Vin Singh cited Baldoni's insights as key to guiding commercialization of the bfLEAP platform.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.